Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to determine if colistin dosage adjustment using 4hr CrCl contribute to better clinical outcomes compared with drug dosage adjustment using eGFR in critical ill patients. In control group, colistin maintenance dosage will be decided using serum creatinine based eGFR (in ml/min). In study group, colistin maintenance dosage will be decided using 4hr CrCl.


Clinical Trial Description

1. Screening periods (From 'informed consents' to 'randomization')

- Check of inclusion/exclusion criteria ② Measurement of 4hr CrCl & eGFR in ml/min

- calculation of maintenance dose ③ Baseline characteristics & laboratory findings ④ Randomization

2. Colistin dosage Loading dose : 5 x body weight (not exceeding 300mg) Maintenance dose (after 12 hours from loading dose)

: 2.5 x ([1.5 x GFR] + 30) (divided doses every 12hours), GFR in ml/min

During the study period, daily morning serm creatinine levels are measured. Whenever serum creatinine concentration changes by more than 10% compared with baseline, 4hr CrCl will be mearued. At the every time of 4hr CrCl measurements, colistin dose wil be modified according to new GFR values (4hr CrCl in study group, eGFR in control group)

3. Blood sampling for Colistin trough level measurement Peripheral blood will be sampled twice between 72 hrs and 144 hours after loading dose, just before colistin infusion. The samples were collected in heparined tubes and centrifuged at 4 °C within 1 hr of collection. The resulting plasma was stored at - 70°C . And two values will be averaged out.

4. End of randomization (7 days after colistin initiation) ① Nephrotoxicity ② Treatment outcome microbiological outcome: eradication / no eradication clinical outcome: complete response / partial response / treatment failure ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03045692
Study type Interventional
Source Samsung Medical Center
Contact Jung Eun Lee, MD,PhD
Phone 82-2-3410-6549
Email jungeun34.lee@samsung.com
Status Not yet recruiting
Phase N/A
Start date February 13, 2017
Completion date April 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04096768 - The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation Phase 3
Recruiting NCT04503876 - Effects of End-expiratory Positive Pressure Optimization in Intubated Patients With Healthy Lung or Acute Respiratory Distress Syndrome N/A
Terminated NCT00922714 - Scandinavian Intensive Care Unit (ICU) Glutamine Study Phase 4
Completed NCT01881672 - Syndrome and Aspiration Pneumonia in Intensive Care N/A
Completed NCT04675424 - Using Artificial Intelligence (AI)-Assisted Pulse Diagnosis Analysis on Precision Critical Medicine.
Completed NCT03977883 - Management of Paroxystic Atrial Fibrillation in French Intensive Care Units
Recruiting NCT04067271 - LUEbeck Registry of Intensive Care Patients - Characterization of the Patients Intestinal MICROBIOME
Completed NCT04811638 - The Validity and Reliability Study of the Chelsea Critical Care Physical Assesment Tool
Completed NCT02161328 - Electric Impedance Tomography Before and After Dilatative Tracheotomy
Completed NCT00714974 - A Prospective, Randomized, Blinded Study of BIS Analysis in ICU Patients Requiring Neuromuscular Blocking Agents N/A
Completed NCT04041817 - Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU N/A
Recruiting NCT02742571 - Validation of PINI Score in ICU N/A